Board Meeting21 Oct 2026, 05:20 pm
Alivus Life Sciences: Trading Window Closure for Q2 FY27 Results
AI Summary
Alivus Life Sciences Ltd has announced the closure of its trading window from October 1, 2026, to October 31, 2026, inclusive. This closure is in preparation for the Board of Directors' meeting scheduled for October 29, 2026. The primary agenda for this meeting is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. The company has informed its designated persons about this trading window restriction as per SEBI regulations.
Key Highlights
- Trading window to close from Oct 1 to Oct 31, 2026.
- Board meeting scheduled for Oct 29, 2026.
- Unaudited financial results for Q2 FY27 to be approved.
- Insider trading regulations are being followed.
- Designated persons informed of the closure.
Price Impact
More from ALIVUS